Literature DB >> 28655643

Activation of sirtuin 1 by catalpol-induced down-regulation of microRNA-132 attenuates endoplasmic reticulum stress in colitis.

Yongjian Xiong1, Liqiang Shi2, Liang Wang2, Zijuan Zhou2, Chenou Wang2, Yuan Lin2, Dong Luo2, Juanjuan Qiu3, Dapeng Chen4.   

Abstract

Defective expression of NAD-dependent protein deacetylase sirtuin 1 (SIRT1) triggers endoplasmic reticulum (ER) stress and epithelial cell apoptosis in inflammatory bowel disease. MicroRNA-132 (miR-132) has been shown to regulate inflammatory processes through down-regulating SIRT1. Catalpol is a potential antioxidant and anti-apoptotic agent in inflammatory disease. This study aimed to investigate the signaling mechanisms underlying catalpol-induced SIRT1 activation and inhibition of ER stress in a rat colitis model. Colitis was established by intracolonic administration of 2, 4, 6-trinitrobenzene sulfonic acid. miR-132 expression was measured by quantitative real-time polymerase chain reaction and in situ hybridization, and the regulation of SIRT1 by miR-132 was examined by dual luciferase reporter assay. Protein expression related to ER stress and apoptosis was measured by western blotting. The ER stress marker proteins ATF6, CHOP, and caspase12, and acetylation of heat-shock factor-1 were increased in colitis and these increases were significantly reversed by catalpol, while the colitis-induced reduction in GRP78 was also reversed by catalpol. The inhibition of ER stress by catalpol was significantly inhibited by small interfering RNA targeting SIRT1 or miR-132. Moreover, other colitis symptoms including infiltration of inflammatory cells, cytokine profiles, oxidative responses, and epithelial cell apoptosis were also significantly decreased by catalpol. Mechanistically, the defective expression of SIRT1 in colitis was significantly counteracted by catalpol, while miR-132, which is a negative targeting regulator of SIRT1, was confirmed as the potential target of catalpol. These results support a link between ER stress and the miR-132/SIRT1/heat-shock factor-1 signaling pathway, and the modulation of this pathway by catalpol in colitis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Catalpol; Catalpol (PubChem CID: 91520); Colitis; Endoplasmic reticulum stress; Inflammatory bowel disease; MicroRNA-132; Sirtuin 1; Sulfasalazine (PubChem CID: 5359476)

Mesh:

Substances:

Year:  2017        PMID: 28655643     DOI: 10.1016/j.phrs.2017.05.030

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  14 in total

1.  LncRNA MIAT Inhibits MPP+-Induced Neuronal Damage Through Regulating the miR-132/SIRT1 Axis in PC12 Cells.

Authors:  Xiaoni Xu; Yajun Zhang; Yonggang Kang; Shujuan Liu; Yarong Wang; Yinxia Wang; Lin Wang
Journal:  Neurochem Res       Date:  2021-09-12       Impact factor: 3.996

Review 2.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

3.  Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro.

Authors:  Jiangnan Zhang; Ran Bi; Qiang Meng; Changyuan Wang; Xiaokui Huo; Zhihao Liu; Chong Wang; Pengyuan Sun; Huijun Sun; Xiaodong Ma; Jingjing Wu; Kexin Liu
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

Review 4.  MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Carlo M Croce
Journal:  Curr Opin Pharmacol       Date:  2017-11-15       Impact factor: 5.547

5.  Ginsenoside Rb1 alleviates colitis in mice via activation of endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 signaling pathway.

Authors:  Jian-Yi Dong; Kai-Jun Xia; Wei Liang; Lu-Lu Liu; Fang Yang; Xue-Sheng Fang; Yong-Jian Xiong; Liang Wang; Zi-Juan Zhou; Chang-Yi Li; Wei-Dong Zhang; Jing-Yu Wang; Da-Peng Chen
Journal:  Acta Pharmacol Sin       Date:  2020-12-02       Impact factor: 7.169

6.  Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury.

Authors:  Xingjuan Gao; Jiaju Xu; Hongbo Liu
Journal:  Mol Med Rep       Date:  2020-07-13       Impact factor: 2.952

7.  Catalpol Protects ARPE-19 Cells against Oxidative Stress via Activation of the Keap1/Nrf2/ARE Pathway.

Authors:  Longtai You; Hulinyue Peng; Jing Liu; Mengru Cai; Huimin Wu; Zhiqin Zhang; Jie Bai; Yu Yao; Xiaoxv Dong; Xingbin Yin; Jian Ni
Journal:  Cells       Date:  2021-10-02       Impact factor: 6.600

8.  Fortunellin-Induced Modulation of Phosphatase and Tensin Homolog by MicroRNA-374a Decreases Inflammation and Maintains Intestinal Barrier Function in Colitis.

Authors:  Yongjian Xiong; Juanjuan Qiu; Changyi Li; Yang Qiu; Li Guo; Yuejian Liu; Jiajia Wan; Yuchun Li; Guokai Wu; Liang Wang; Zijuan Zhou; Jianyi Dong; Chunhua Du; Dapeng Chen; Huishu Guo
Journal:  Front Immunol       Date:  2018-01-26       Impact factor: 7.561

Review 9.  The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.

Authors:  Adam Włodarski; Justyna Strycharz; Adam Wróblewski; Jacek Kasznicki; Józef Drzewoski; Agnieszka Śliwińska
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

Review 10.  Research Progress on Catalpol as Treatment for Atherosclerosis.

Authors:  Lei He; Rusheng Zhao; Youheng Wang; Huibing Liu; Xuehui Wang
Journal:  Front Pharmacol       Date:  2021-07-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.